Susquehanna International Group
NVO

Susquehanna International Group’s Novo Nordisk NVO Stock Holding History

Susquehanna International Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$408M Buy
11,106,111
+9,884,077
+809% +$468M 0.05% 315
2025
Q4 		$62.2M Buy
1,222,034
+568,343
+87% +$29.1M 0.01% 1197
2025
Q3 		$36.3M Sell
653,691
-753,067
-54% -$44.1M ﹤0.01% 1611
2025
Q2 		$97.1M Sell
1,406,758
-8,155
-0.6% -$555K 0.01% 773
2025
Q1 		$98.3M Buy
1,414,913
+1,129,205
+395% +$93.3M 0.02% 657
2024
Q4 		$24.6M Sell
285,708
-603,994
-68% -$65.3M ﹤0.01% 1697
2024
Q3 		$106M Buy
889,702
+540,895
+155% +$72.1M 0.02% 621
2024
Q2 		$49.8M Sell
348,807
-726,875
-68% -$96.3M 0.01% 994
2024
Q1 		$138M Buy
1,075,682
+886,667
+469% +$106M 0.02% 530
2023
Q4 		$19.6M Buy
189,015
+92,442
+96% +$9.14M ﹤0.01% 1845
2023
Q3 		$8.78M Sell
96,573
-26,107
-21% -$2.3M ﹤0.01% 2732
2023
Q2 		$9.93M Buy
122,680
+40,194
+49% +$3.28M ﹤0.01% 2509
2023
Q1 		$6.56M Sell
82,486
-39,430
-32% -$2.8M ﹤0.01% 3045
2022
Q4 		$8.25M Sell
121,916
-53,172
-30% -$3.12M ﹤0.01% 2519
2022
Q3 		$8.72M Sell
175,088
-1,474
-0.8% -$79K ﹤0.01% 2362
2022
Q2 		$9.84M Sell
176,562
-544,568
-76% -$30.2M ﹤0.01% 2220
2022
Q1 		$40M Buy
721,130
+260,618
+57% +$13.4M 0.01% 1147
2021
Q4 		$25.8M Sell
460,512
-41,566
-8% -$2.25M ﹤0.01% 1599
2021
Q3 		$24.1M Buy
502,078
+15,894
+3% +$768K ﹤0.01% 1789
2021
Q2 		$20.4M Buy
486,184
+302,380
+165% +$11.7M ﹤0.01% 2006
2021
Q1 		$6.2M Buy
183,804
+148,154
+416% +$5.28M ﹤0.01% 3513
2020
Q4 		$1.25M Sell
35,650
-33,212
-48% -$1.15M ﹤0.01% 6184
2020
Q3 		$2.39M Sell
68,862
-62,966
-48% -$2.1M ﹤0.01% 4278
2020
Q2 		$4.32M Sell
131,828
-34,676
-21% -$1.11M ﹤0.01% 3214
2020
Q1 		$5.01M Buy
166,504
+140,224
+534% +$4.18M ﹤0.01% 2564
2019
Q4 		$761K Sell
26,280
-139,860
-84% -$3.87M ﹤0.01% 6072
2019
Q3 		$4.29M Buy
166,140
+91,182
+122% +$2.31M ﹤0.01% 2928
2019
Q2 		$1.91M Buy
74,958
+32,252
+76% +$797K ﹤0.01% 4258
2019
Q1 		$1.12M Buy
+42,706
New +$1.05M ﹤0.01% 4832
2018
Q4 		– Sell
-193,050
Closed -$4.29M – 9660
2018
Q3 		$4.55M Buy
+193,050
New +$4.71M ﹤0.01% 2809
2018
Q2 		– Sell
-99,956
Closed -$2.38M – 10135
2018
Q1 		$2.46M Buy
+99,956
New +$2.62M ﹤0.01% 3546
2017
Q3 		– Sell
-410,718
Closed -$9.28M – 9379
2017
Q2 		$8.81M Buy
410,718
+48,616
+13% +$981K ﹤0.01% 1812
2017
Q1 		$6.21M Buy
362,102
+86,810
+32% +$1.51M ﹤0.01% 2119
2016
Q4 		$4.94M Sell
275,292
-119,366
-30% -$2.16M ﹤0.01% 2460
2016
Q3 		$8.21M Buy
394,658
+143,496
+57% +$3.56M ﹤0.01% 1689
2016
Q2 		$6.75M Sell
251,162
-166,302
-40% -$4.56M ﹤0.01% 1843
2016
Q1 		$11.3M Buy
417,464
+344,450
+472% +$9.23M 0.01% 1439
2015
Q4 		$2.12M Buy
73,014
+29,004
+66% +$803K ﹤0.01% 3921
2015
Q3 		$1.19M Sell
44,010
-141,872
-76% -$4.02M ﹤0.01% 5327
2015
Q2 		$5.09M Sell
185,882
-13,144
-7% -$369K ﹤0.01% 2885
2015
Q1 		$5.31M Buy
199,026
+152,660
+329% +$3.52M ﹤0.01% 2659
2014
Q4 		$981K Sell
46,366
-8,852
-16% -$198K ﹤0.01% 5917
2014
Q3 		$1.31M Sell
55,218
-52,416
-49% -$1.21M ﹤0.01% 5391
2014
Q2 		$2.48M Sell
107,634
-55,326
-34% -$1.22M ﹤0.01% 4236
2014
Q1 		$3.72M Buy
162,960
+106,320
+188% +$2.27M ﹤0.01% 3321
2013
Q4 		$1.05M Sell
56,640
-636,840
-92% -$11.1M ﹤0.01% 5427
2013
Q3 		$11.7M Buy
693,480
+233,370
+51% +$3.93M 0.01% 1735
2013
Q2 		$7.13M Buy
+460,110
New +$7.66M ﹤0.01% 2191

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Susquehanna International Group's NVO Position: Q1 2026 in Review

Susquehanna International Group increased its Novo Nordisk (NVO) stake by 809% in Q1 2026, buying an estimated $468M and bringing the position to 11,106,111 shares worth $408M. The position accounts for 0.05% of the portfolio, ranked #315.

Susquehanna International Group first reported a position in NVO in Q2 2013 and has held it in 48 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Susquehanna International Group held 11,106,111 shares of Novo Nordisk worth $408M as of Q1 2026.
  • Susquehanna International Group bought 9,884,077 Novo Nordisk shares in Q1 2026, an estimated $468M.
  • Novo Nordisk made up 0.05% of Susquehanna International Group's portfolio in Q1 2026, its #315 holding.
  • Susquehanna International Group first reported a position in Novo Nordisk in Q2 2013 and has held it in 48 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.